Clinical Study
Testing Spesolimab for Adults with Hidradenitis Suppurativa
Hidradenitis Suppurativa is a skin condition that causes painful lumps and soars on parts of the body such as the armpit. This study will test a drug called Spesolimab to treat adults with this disease. The study wants to see if the drug will help people with this disease and is safe. People in this study will be randomly chosen to be treated with Spesolimab or a placebo for 16 weeks. The study drug and placebo are taken as infusions (a liquid drug given under the skin) for 4 weeks at the beginning of participation. Then the drug is given as an injection (liquid drug given instantly into the skin) for the remainder of the study. After 16 weeks all participants will be given the study drug. Being in this study requires 31 study visits at the clinic for a little over a year. Medical tests will be done during the study to track the health of participants.
For more information contact:
Sean Wentland
sean.wentland@hsc.utah.edu
801-213-3427
IRB#: IRB_00167413
| PI: Jamie Rhoads
| Department: DERMATOLOGY
| Approval Date: 2024-03-20 06:00:00
Specialties: Dermatology
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria:
- Ages 18 years and older
- Diagnosis of Hidradenitis Suppurativa
- Current conditions (painful lump and soar) of the disease on at least 2 specific parts of the body
- Willing and able to use specific birth control
- Able to attend in person at the study clinic
Exclusion Criteria:
- Willing and able to stop using any other drug that may interfere with Spesolimab
- Prior use of Spesolimab
- Major surgery 12 weeks before participation
- Specific chronic infections including HIV
- Pregnant or nursing
Will I be paid for my time?
Yes